Michael Calhoun

Michael Calhoun is an accomplished technology and product development leader with extensive experience in the healthcare and neuroscience sectors. Currently serving as the CTO and Head of Product at Reveal-Dx since June 2021, Michael oversees R&D, regulatory, and product development to advance precision medicine for lung care. Previously, as CEO of Mindshare Medical from August 2014 to June 2021, Michael played a pivotal role in the development of RevealAI-Lung, an AI-driven product enhancing lung nodule analysis. Michael's earlier endeavors include founding and directing Sinq Systems, leading research on Alzheimer's at the Hertie Institute, and pioneering neural network research at Mount Sinai School of Medicine. Michael holds a Ph.D. in Neuroscience from the University of Basel and a B.A. in Computer Science from Boston University.